Bragar Eagel & Squire, P.C. Is Investigating Everbridge, Aligos, Clariant, and Natera and Encourages Investors to Contact the Firm
21 févr. 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, Feb. 21, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Everbridge, Inc. (NASDAQ:...
Bragar Eagel & Squire, P.C. Is Investigating Everbridge, Aligos, SunPower, and Natera and Encourages Investors to Contact the Firm
16 févr. 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Everbridge, Inc. (NASDAQ:...
Bragar Eagel & Squire, P.C. Is Investigating Everbridge, Aligos, Labcorp., and SunPower and Encourages Investors to Contact the Firm
11 févr. 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, Feb. 11, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Everbridge, Inc. (NASDAQ:...
Bragar Eagel & Squire, P.C. Is Investigating Everbridge, Hollysys, Aligos, and Labcorp. and Encourages Investors to Contact the Firm
31 janv. 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Everbridge, Inc. (NASDAQ:...
Bragar Eagel & Squire, P.C. Is Investigating Aligos, SunPower, and Labcorp and Encourages Investors to Contact the Firm
26 janv. 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Aligos Therapeutics, Inc....